These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6246788)

  • 21. Modulation of phagocytosis by and lysosomal enzyme secretion from guinea-pig neutrophils: effect of nonsteroid anti-inflammatory agents and prostaglindins.
    Smith RJ
    J Pharmacol Exp Ther; 1977 Mar; 200(3):647-57. PubMed ID: 850132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin mediation of potassium effects on renin release.
    Lazar JD; Whorton AR
    Life Sci; 1980 Oct; 27(14):1327-33. PubMed ID: 6777616
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of in vitro lysozyme release from human granulocytes and monocytes by non-steroidal anti-inflammatory agents.
    Haneberg B; Sørnes S; Bakke O; Solberg CO
    Acta Pathol Microbiol Immunol Scand C; 1987 Aug; 95(4):149-53. PubMed ID: 3673588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carrageenan-induced suppression of T-lymphocyte proliferation in the rat: abrogation of suppressor factor production by the prostaglandin synthesis inhibitors, indomethacin and ETYA.
    Cochran FR; Baxter CS
    Immunobiology; 1984 May; 166(3):275-85. PubMed ID: 6610628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inactivation of lipoxygenases by acetylenic fatty acids.
    Kühn H; Schewe T; Rapoport SM
    Biomed Biochim Acta; 1984; 43(8-9):S358-61. PubMed ID: 6440550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid metabolism during mediator release from mast cells: studies of the role of arachidonic acid metabolism in the control of phospholipid metabolism.
    Marquardt DL; Nicolotti RA; Kennerly DA; Sullivan TJ
    J Immunol; 1981 Sep; 127(3):845-9. PubMed ID: 6167627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cyanidanol-3 on lysosomal enzyme activity of serum and granulocytes in chronic liver disease and active hepatitis.
    Fehér J; Toncsev H; Sréter L; Cornides A; Kiss A
    Int J Tissue React; 1984; 6(1):75-80. PubMed ID: 6715121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyunsaturated fatty acids, vitamin E, and the proliferation of aortic smooth muscle cells.
    Cornwell DG; Huttner JJ; Milo GE; Panganamala RV; Sharma HM; Geer JC
    Lipids; 1979 Feb; 14(2):194-207. PubMed ID: 423721
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of immunoglobulin E-mediated, antigen-induced monkey asthma and skin reactions by 5, 8, 11, 14-eicosatetraynoic acid.
    Patterson R; Harris KE
    J Allergy Clin Immunol; 1981 Feb; 67(2):146-52. PubMed ID: 6161146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible role of arachidonic acid and its metabolites in mediator release from rat mast cells.
    Sullivan TJ; Parker CW
    J Immunol; 1979 Feb; 122(2):431-6. PubMed ID: 762430
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of cytotoxic T lymphocyte-mediated lysis by ETYA: effect independent of arachidonic acid metabolism.
    Taylor AS; Howe RC; Morrison AR; Sprecher H; Russell JH
    J Immunol; 1985 Feb; 134(2):1130-5. PubMed ID: 2981259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of U937 cells induced by 5,8,11,14-eicosatetraynoic acid, a competitive inhibitor of arachidonic acid metabolism.
    Ondrey F; Anderson K; Hoeltgen D; Harris J
    Exp Cell Res; 1988 Dec; 179(2):477-87. PubMed ID: 3142783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor cell mitochondrial matrix/cristae complexes as potential sites for anticancer therapy with polyunsaturated fatty acid analogues.
    Anderson KM; Seed T; Ondrey F; Wilson D; Harris JE
    Prostaglandins Leukot Essent Fatty Acids; 1990 Jun; 40(2):137-41. PubMed ID: 2385613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of allergic and nonallergic histamine secretion by lipoxygenase inhibitors.
    Chand N; Diamantis W; Pillar J; Sofia RD
    Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):49-57. PubMed ID: 2436271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of FPL 55712, ETYA and aminophylline upon Ascaris-induced bronchoconstriction in cynomolgus monkeys.
    Mielens ZE; Gorman WG
    Int Arch Allergy Appl Immunol; 1984; 75(4):368-74. PubMed ID: 6500722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triple-bonded unsaturated fatty acids are redox active compounds.
    Peterson DA; Reeve HL; Nelson D; Archer SL; Weir EK
    Lipids; 2001 Apr; 36(4):431-3. PubMed ID: 11383698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indomethacin--a calcium antagonist.
    Northover BJ
    Gen Pharmacol; 1977; 8(5-6):293-6. PubMed ID: 342333
    [No Abstract]   [Full Text] [Related]  

  • 38. Arachidonic acid analogues: an additional class of membrane--active agents with potential anticancer activity.
    Anderson KM; Ondrey F; Harris JE
    Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(4):231-41. PubMed ID: 2654962
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in cellular enzyme levels and the inhibition of selective release of lysosomal hydrolases from macrophages by indomethacin.
    Finlay C; Davies P; Allison AC
    Agents Actions; 1975 Oct; 5(4):345-53. PubMed ID: 1211308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombin effects on cultured nerve cells: clinical implications and evidence for a novel mechanism of neuronal activation.
    Snider RM
    Ann N Y Acad Sci; 1986; 485():310-3. PubMed ID: 3032048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.